{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:27:32Z","timestamp":1786962452499,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"23","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100031022","name":"HHS | NIH | NCI | Center for Cancer Research","doi-asserted-by":"publisher","award":["R01CA258736"],"award-info":[{"award-number":["R01CA258736"]}],"id":[{"id":"10.13039\/100031022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","award":["Wolfson Fellowship"],"award-info":[{"award-number":["Wolfson Fellowship"]}],"id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Scotland Chief Scientific Office","award":["EPD\/22\/13"],"award-info":[{"award-number":["EPD\/22\/13"]}]},{"name":"Scotland Chief Scientific Office","award":["TCS\/22\/02"],"award-info":[{"award-number":["TCS\/22\/02"]}]},{"DOI":"10.13039\/501100018703","name":"CRUK | Beatson Institute for Cancer Research","doi-asserted-by":"publisher","award":["CTRQQR-2021\\100006"],"award-info":[{"award-number":["CTRQQR-2021\\100006"]}],"id":[{"id":"10.13039\/501100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009232","name":"Beatson Cancer Charity","doi-asserted-by":"publisher","award":["24-25-045 BCC"],"award-info":[{"award-number":["24-25-045 BCC"]}],"id":[{"id":"10.13039\/100009232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Rep"],"published-print":{"date-parts":[[2025,12,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Approximately 40% of colorectal cancer (CRC) cases are characterised by KRAS mutations, rendering them insensitive to most therapies. While the reasons for this resistance remain incompletely understood, one key aspect is genetic complexity: in CRC, oncogenic KRAS is most commonly paired with mutations that alter WNT and P53 activities (\u201cRAP\u201d). Here, we demonstrate that elevated WNT activity upregulates canonical NF-\u03baB signalling in both\n                    <jats:italic>Drosophila<\/jats:italic>\n                    and human RAS mutant tumours. This upregulation was enhanced by P53 loss and required immune-associated factors Toll-1 and Toll-9. These changes reduced efficacy of Ras pathway-targeting drugs such as trametinib due to NF-\u03baB-dependent enhancement of the glucuronidation detoxifying pathway, likely through modulating gene transcription and glucose uptake. Inhibiting WNT activity pharmacologically suppressed trametinib resistance in RAP tumours and more genetically complex \u2018patient avatar\u2019 models. The efficacy of WNT\/MEK drug inhibitor combinations was further enhanced by targeting\n                    <jats:italic>brm<\/jats:italic>\n                    ,\n                    <jats:italic>shg<\/jats:italic>\n                    ,\n                    <jats:italic>ago<\/jats:italic>\n                    ,\n                    <jats:italic>rhoGAPp190<\/jats:italic>\n                    , and\n                    <jats:italic>upf1<\/jats:italic>\n                    , potential biomarkers for patients responsive to this dual therapeutic approach. These findings shed light on how genetic complexity impacts drug resistance and a strategy to overcome it.\n                  <\/jats:p>","DOI":"10.1038\/s44319-025-00588-1","type":"journal-article","created":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:19:20Z","timestamp":1762273160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["WNT signalling promotes NF-\u03baB activation and drug resistance in KRAS-mutant colorectal cancer"],"prefix":"10.1038","volume":"26","author":[{"given":"Bojie","family":"Cong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelia","family":"Stamou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-1331","authenticated-orcid":false,"given":"Kathryn","family":"Pennel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teena","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Mckenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna","family":"Matly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-194X","authenticated-orcid":false,"given":"Kathryn","family":"Gilroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhura","family":"Gopinath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-6906","authenticated-orcid":false,"given":"Joanne","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5297-450X","authenticated-orcid":false,"given":"Ross","family":"Cagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"588_CR1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cjp2.193","volume":"7","author":"SS Al\u2010Badran","year":"2021","unstructured":"Al\u2010Badran SS, Grant L, Campo MV, Inthagard J, Pennel K, Quinn J, Konanahalli P, Hayman L, Horgan PG, McMillan DC et al (2021) Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer. J Pathol Clin Res 7:121\u2013134","journal-title":"J Pathol Clin Res"},{"key":"588_CR2","doi-asserted-by":"crossref","first-page":"eaav6528","DOI":"10.1126\/sciadv.aav6528","volume":"5","author":"E Bangi","year":"2019","unstructured":"Bangi E, Ang C, Smibert P, Uzilov AV, Teague AG, Antipin Y, Chen R, Hecht C, Gruszczynski N, Yon WJ et al (2019) A personalized platform identifies trametinib plus zoledronate for a patient with KRAS-mutant metastatic colorectal cancer. Sci Adv 5:eaav6528","journal-title":"Sci Adv"},{"key":"588_CR3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13615","volume":"7","author":"E Bangi","year":"2016","unstructured":"Bangi E, Murgia C, Teague AGS, Sansom OJ, Cagan RL (2016) Functional exploration of colorectal cancer genomes using Drosophila. Nat Commun 7:13615","journal-title":"Nat Commun"},{"key":"588_CR4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead P, Loughrey MB, Fern\u00e1ndez JA, Dombrowski Y, McArt DG, Dunne PD, McQuaid S, Gray RT, Murray LJ, Coleman HG et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7:16878","journal-title":"Sci Rep"},{"key":"588_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.onc.1206056","volume":"22","author":"M Bentires-Alj","year":"2003","unstructured":"Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville M-P, Bours V (2003) NF-\u03baB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene 22:90\u201397","journal-title":"Oncogene"},{"key":"588_CR6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1101\/gad.293449.116","volume":"31","author":"AT Boutin","year":"2017","unstructured":"Boutin AT, Liao W-T, Wang M, Hwang SS, Karpinets TV, Cheung H, Chu GC, Jiang S, Hu J, Chang K et al (2017) Oncogenic Kras drives invasion and maintains metastases in colorectal cancer. Genes Dev 31:370\u2013382","journal-title":"Genes Dev"},{"key":"588_CR7","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/ijc.23383","volume":"122","author":"SR Calcagno","year":"2008","unstructured":"Calcagno SR, Li S, Colon M, Kreinest PA, Thompson EA, Fields AP, Murray NR (2008) OncogenicK-ras promotes early carcinogenesis in the mouse proximal colon. Int J Cancer 122:2462\u20132470","journal-title":"Int J Cancer"},{"key":"588_CR8","doi-asserted-by":"crossref","first-page":"E2682","DOI":"10.1073\/pnas.1613917114","volume":"114","author":"A Capilla","year":"2017","unstructured":"Capilla A, Karachentsev D, Patterson RA, Hermann A, Juarez MT, McGinnis W (2017) Toll pathway is required for wound-induced expression of barrier repair genes in the Drosophila epidermis. Proc Natl Acad Sci USA 114:E2682\u2013E2688","journal-title":"Proc Natl Acad Sci USA"},{"key":"588_CR9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrd3385","volume":"10","author":"G Caponigro","year":"2011","unstructured":"Caponigro G, Sellers WR (2011) Advances in the preclinical testing of cancer therapeutic hypotheses. Nat Rev Drug Discov 10:179\u2013187","journal-title":"Nat Rev Drug Discov"},{"key":"588_CR10","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1038\/s41388-025-03472-3","volume":"44","author":"B Cong","year":"2025","unstructured":"Cong B, Thakur T, Uribe AH, Stamou E, Gopinath S, Sansom O, Maddocks O, Cagan R (2025) Colon cancer cells evade drug action by enhancing drug metabolism. Oncogene 44:3284\u20133296","journal-title":"Oncogene"},{"key":"588_CR11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.devcel.2010.05.014","volume":"18","author":"JB Cordero","year":"2010","unstructured":"Cordero JB, Macagno JP, Stefanatos RK, Strathdee KE, Cagan RL, Vidal M (2010) Oncogenic Ras diverts a host TNF tumor suppressor activity into tumor promoter. Dev Cell 18:999\u20131011","journal-title":"Dev Cell"},{"key":"588_CR12","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S1470-2045(15)00122-9","volume":"16","author":"C Cremolini","year":"2015","unstructured":"Cremolini C, Loupakis F, Antoniotti C, Lupi C, Sensi E, Lonardi S, Mezi S, Tomasello G, Ronzoni M, Zaniboni A et al (2015) FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study. Lancet Oncol 16:1306\u20131315","journal-title":"Lancet Oncol"},{"key":"588_CR13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1158\/0008-5472.CAN-15-1519","volume":"76","author":"L Fang","year":"2016","unstructured":"Fang L, Zhu Q, Neuenschwander M, Specker E, Wulf-Goldenberg A, Weis WI, Von Kries JP, Birchmeier W (2016) A small-molecule antagonist of the \u03b2-catenin\/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis. Cancer Res 76:891\u2013901","journal-title":"Cancer Res"},{"key":"588_CR14","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/0092-8674(90)90186-I","volume":"61","author":"ER Fearon","year":"1990","unstructured":"Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759\u2013767","journal-title":"Cell"},{"key":"588_CR15","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0092-8674(92)90595-4","volume":"71","author":"R Geisler","year":"1992","unstructured":"Geisler R, Bergmann A, Hiromi Y, N\u00fcsslein-Volhard C (1992) cactus, a gene involved in dorsoventral pattern formation of Drosophila, is related to the I\u03baB gene family of vertebrates. Cell 71:613\u2013621","journal-title":"Cell"},{"key":"588_CR16","doi-asserted-by":"crossref","first-page":"5098","DOI":"10.4049\/jimmunol.0803446","volume":"182","author":"D Hartl","year":"2009","unstructured":"Hartl D, He CH, Koller B, Da Silva CA, Kobayashi Y, Lee CG, Flavell RA, Elias JA (2009) Acidic mammalian chitinase regulates epithelial cell apoptosis via a chitinolytic-independent mechanism. J Immunol 182:5098\u20135106","journal-title":"J Immunol"},{"key":"588_CR17","doi-asserted-by":"crossref","first-page":"re13","DOI":"10.1126\/stke.3572006re13","volume":"2006","author":"H H\u00e4cker","year":"2006","unstructured":"H\u00e4cker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13","journal-title":"Sci STKE"},{"key":"588_CR18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1158\/2159-8290.CD-21-1331","volume":"12","author":"MH Hofmann","year":"2022","unstructured":"Hofmann MH, Gerlach D, Misale S, Petronczki M, Kraut N (2022) Expanding the reach of precision oncology by drugging all KRAS mutants. Cancer Discov 12:924\u2013937","journal-title":"Cancer Discov"},{"key":"588_CR19","volume":"10","author":"B Hu","year":"2020","unstructured":"Hu B, Xu Y, Li Y, Huang J, Cheng J, Guo W, Yin Y, Gao Y, Wang P, Wu S et al (2020) CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5\u2010LSD1\u2010NF\u2010\u03baB oncogenic signaling. Clin Transl Med 10:e233","journal-title":"Clin Transl Med"},{"key":"588_CR20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang L, Guo Z, Wang F, Fu L (2021) KRAS mutation: from undruggable to druggable in cancer. Signal Transduct Target Ther 6:386","journal-title":"Signal Transduct Target Ther"},{"key":"588_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0962-8924(01)02004-9","volume":"11","author":"J-L Imler","year":"2001","unstructured":"Imler J-L, Hoffmann JA (2001) Toll receptors in innate immunity. Trends Cell Biol 11:304\u2013311","journal-title":"Trends Cell Biol"},{"key":"588_CR22","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(12)70270-X","volume":"13","author":"JR Infante","year":"2012","unstructured":"Infante JR, Fecher LA, Falchook GS, Nallapareddy S, Gordon MS, Becerra C, DeMarini DJ, Cox DS, Xu Y, Morris SR et al (2012) Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol 13:773\u2013781","journal-title":"Lancet Oncol"},{"key":"588_CR23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0092-8674(92)90596-5","volume":"71","author":"S Kidd","year":"1992","unstructured":"Kidd S (1992) Characterization of the Drosophila cactus locus and analysis of interactions between cactus and dorsal proteins. Cell 71:623\u2013635","journal-title":"Cell"},{"key":"588_CR43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.immuni.2017.09.011","volume":"47","author":"A Kleino","year":"2017","unstructured":"Kleino A, Ramia NF, Bozkurt G, Shen Y, Nailwal H, Huang J, Napetschnig J, Gangloff M, Chan FK-M, Wu H, Li J, Silverman N (2017) Peptidoglycan-sensing receptors trigger the formation of functional amyloids of the adaptor protein Imd to initiate Drosophila NF-\u03baB signaling. Immunity 47:635\u2013647.e6","journal-title":"Immunity"},{"key":"588_CR24","volume":"12","author":"S Kumar","year":"2021","unstructured":"Kumar S, Nandi A, Singh S, Regulapati R, Li N, Tobias JW, Siebel CW, Blanco MA, Klein-Szanto AJ, Lengner C et al (2021) Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-\u03baB survival pathway. Nat Commun 12:432","journal-title":"Nat Commun"},{"key":"588_CR25","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1073\/pnas.95.7.3792","volume":"95","author":"L Ling","year":"1998","unstructured":"Ling L, Cao Z, Goeddel DV (1998) NF-\u03baB-inducing kinase activates IKK-\u03b1 by phosphorylation of Ser-176. Proc Natl Acad Sci USA 95:3792\u20133797","journal-title":"Proc Natl Acad Sci USA"},{"key":"588_CR26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1101\/gad.13.7.792","volume":"13","author":"X Meng","year":"1999","unstructured":"Meng X, Khanuja BS, Ip YT (1999) Toll receptor-mediated Drosophila immune response requires Dif, an NF-kappa B factor. Genes Dev 13:792\u2013797","journal-title":"Genes Dev"},{"key":"588_CR27","doi-asserted-by":"crossref","first-page":"6749","DOI":"10.1038\/sj.onc.1209940","volume":"25","author":"S Minakhina","year":"2006","unstructured":"Minakhina S, Steward R (2006) Nuclear factor-kappa B pathways in Drosophila. Oncogene 25:6749\u20136757","journal-title":"Oncogene"},{"key":"588_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules26247463","volume":"26","author":"M Nalli","year":"2021","unstructured":"Nalli M, Puxeddu M, La Regina G, Gianni S, Silvestri R (2021) Emerging therapeutic agents for colorectal cancer. Molecules 26:1\u201326","journal-title":"Molecules"},{"key":"588_CR29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.33811","volume":"150","author":"A Neiheisel","year":"2022","unstructured":"Neiheisel A, Kaur M, Ma N, Havard P, Shenoy AK (2022) Wnt pathway modulators in cancer therapeutics: an update on completed and ongoing clinical trials. Int J Cancer 150:727\u2013740","journal-title":"Int J Cancer"},{"key":"588_CR30","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature11903","volume":"494","author":"Network TCGAR","year":"2013","unstructured":"Network TCGAR (2013) Erratum: corrigendum: comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 494:506\u2013506","journal-title":"Nature"},{"key":"588_CR31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1126\/science.1088474","volume":"302","author":"RA Pagliarini","year":"2003","unstructured":"Pagliarini RA, Xu T (2003) A genetic screen in Drosophila for metastatic behavior. Science 302:1227\u20131231","journal-title":"Science"},{"key":"588_CR32","doi-asserted-by":"crossref","first-page":"6685","DOI":"10.1038\/sj.onc.1209934","volume":"25","author":"C Scheidereit","year":"2006","unstructured":"Scheidereit C (2006) I\u03baB kinase complexes: gateways to NF-\u03baB activation and transcription. Oncogene 25:6685\u20136705","journal-title":"Oncogene"},{"key":"588_CR33","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1158\/0008-5472.CAN-07-1599","volume":"67","author":"ALB Seynhaeve","year":"2007","unstructured":"Seynhaeve ALB, Hoving S, Schipper D, Vermeulen CE, aan de Wiel-Ambagtsheer G, van Tiel ST, Eggermont AMM, ten Hagen TLM (2007) Tumor necrosis factor \u03b1 mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response. Cancer Res 67:9455\u20139462","journal-title":"Cancer Res"},{"key":"588_CR34","doi-asserted-by":"crossref","first-page":"110817","DOI":"10.1016\/j.celrep.2022.110817","volume":"39","author":"A Shields","year":"2022","unstructured":"Shields A, Amcheslavsky A, Brown E, Lee TV, Nie Y, Tanji T, Ip YT, Bergmann A (2022) Toll-9 interacts with Toll-1 to mediate a feedback loop during apoptosis-induced proliferation in Drosophila. Cell Rep 39:110817","journal-title":"Cell Rep"},{"key":"588_CR35","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1204040","volume":"331","author":"MR Stratton","year":"2011","unstructured":"Stratton MR (2011) Exploring the genomes of cancer cells: progress and promise. Science 331:1553\u20131558","journal-title":"Science"},{"key":"588_CR36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nature07943","volume":"458","author":"MR Stratton","year":"2009","unstructured":"Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719\u2013724","journal-title":"Nature"},{"key":"588_CR37","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"588_CR44","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.celrep.2019.07.015","volume":"28","author":"M Suzawa","year":"2019","unstructured":"Suzawa M, Muhammad NM, Joseph BS, Bland ML (2019) The Toll signaling pathway targets the insulin-like peptide Dilp6 to inhibit growth in Drosophila. Cell Rep 28:1439\u20131446.e5","journal-title":"Cell Rep"},{"key":"588_CR38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0968-0896(02)00440-6","volume":"11","author":"M Tobe","year":"2003","unstructured":"Tobe M, Isobe Y, Tomizawa H, Nagasaki T, Takahashi H, Fukazawa T, Hayashi H (2003) Discovery of quinazolines as a novel structural class of potent inhibitors of NF-\u03baB activation. Bioorg Med Chem 11:383\u2013391","journal-title":"Bioorg Med Chem"},{"key":"588_CR39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/prot.20955","volume":"64","author":"J Trosset","year":"2006","unstructured":"Trosset J, Dalvit C, Knapp S, Fasolini M, Veronesi M, Mantegani S, Gianellini LM, Catana C, Sundstr\u00f6m M, Stouten PFW et al (2006) Inhibition of protein\u2013protein interactions: the discovery of druglike \u03b2\u2010catenin inhibitors by combining virtual and biophysical screening. Proteins 64:60\u201367","journal-title":"Proteins"},{"key":"588_CR40","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.3390\/cancers14122928","volume":"14","author":"Q Wang","year":"2022","unstructured":"Wang Q, Shen X, Chen G, Du J (2022) Drug resistance in colorectal cancer: from mechanism to clinic. Cancers 14:2928","journal-title":"Cancers"},{"key":"588_CR41","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, Jayakumaran G, Middha S, Zehir A, Donoghue MTA et al (2018) Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell 33:125\u2013136.e3","journal-title":"Cancer Cell"},{"key":"588_CR42","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bbrc.2018.06.158","volume":"503","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Wang C, Han X, Yang G, Ge Z, Zhang G (2018) Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation. Biochem Biophys Res Commun 503:2333\u20132339","journal-title":"Biochem Biophys Res Commun"}],"container-title":["EMBO Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44319-025-00588-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44319-025-00588-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T09:54:19Z","timestamp":1786960459000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44319-025-00588-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":44,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,12,4]]}},"alternative-id":["588"],"URL":"https:\/\/doi.org\/10.1038\/s44319-025-00588-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.12.21.572810","asserted-by":"object"}]},"ISSN":["1469-221X","1469-3178"],"issn-type":[{"value":"1469-221X","type":"print"},{"value":"1469-3178","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"7"}}